Page last updated: 2024-12-06

poly-n,n-dimethyl-n,n-diallylammonium chloride

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

Poly-N,N-dimethyl-N,N-diallylammonium chloride (polyDADMAC) is a cationic polyelectrolyte commonly used as a flocculant, coagulant, and biocide. It is synthesized by the polymerization of diallyldimethylammonium chloride (DADMAC). PolyDADMAC is effective in removing suspended solids, such as algae, bacteria, and organic matter, from water. It is also used in the production of paper, textiles, and paints. PolyDADMAC is studied for its potential applications in wastewater treatment, environmental remediation, and other industrial processes. The compound has shown some toxicity, and its environmental impact is under investigation.'
```

diallyldimethylammonium chloride: structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID33286
CHEMBL ID3185104
SCHEMBL ID20731
MeSH IDM0121783

Synonyms (80)

Synonym
nsc59284
dimethyldiallylammonium chloride
2-propen-1-aminium,n-dimethyl-n-2-propenyl-, chloride
nsc-59284
diallyldimethylammonium chloride
7398-69-8
vpk 402
e 261
pas-h 10
agefloc wt 20
cp 261lv
calgon 261lv
quaternium-40
percol 1697
calgon 261
pbk 1
quaternium 40
merquat 100
261lv
cp 261
lectrapel
cat-floc
merck 261
diallyl dimethyl ammonium chloride
ccris 8977
einecs 230-993-8
ammonium, diallyldimethyl-, chloride
hsdb 7258
nsc 59284
n,n-dimethyl-n-2-propenyl-2-propen-1-aminium chloride
2-propen-1-aminium, n,n-dimethyl-n-2-propenyl-, chloride
n-allyl-n,n-dimethylprop-2-en-1-aminium chloride
dimethyl-bis(prop-2-enyl)azanium chloride
D2003
A837990
dimethyl-bis(prop-2-enyl)ammonium chloride
C-1615 ,
dtxcid407650
NCGC00257309-01
dtxsid4027650 ,
tox21_303355
cas-7398-69-8
tox21_201695
NCGC00259244-01
163bbm0b4x ,
yfl33x52px ,
unii-163bbm0b4x
col 1620
unii-yfl33x52px
26062-79-3
FT-0689120
dimethyl diallyl ammonium chloride
2-propen-1-aminium, n,n-dimethyl-n-2-propen-1-yl-, chloride (1:1)
ec 230-993-8
unii-8mc08b895b
8mc08b895b ,
FT-0624610
AKOS015902051
diallyldimethyl ammonium chloride [inci]
unisence fpa 1002l
new frontier c 1615
diallyldimethylammonium chloride [hsdb]
dadmac
nalco 7544
diallyldimethyl ammonium chloride
SCHEMBL20731
GQOKIYDTHHZSCJ-UHFFFAOYSA-M
n,n-dimethyldiallylammonium chloride
W-104440
CHEMBL3185104
diallyldimethylammonium chloride (60% in water)
mfcd00043200
Q27270755
dimethyl-bis(prop-2-enyl)azanium;chloride
STARBLD0003664
CS-0167991
2-propen-1-aminium, n,n-dimethyl-n-2-propenyl-, chloride,homopolymer
F71242
HY-W106486
diallyldimethylammoniumchloride(60%inwater)

Research Excerpts

Dosage Studied

ExcerptRelevanceReference
"Previous research has shown that dosing polymers directly to the saturator of a dissolved air flotation (DAF) process in replacement of upstream coagulation can achieve algae removal comparable to that of conventional treatment, as a result of bubble modification."( Polymers as bubble surface modifiers in the flotation of algae.
Henderson, RK; Jefferson, B; Parsons, SA, 2010
)
0.36
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Protein Targets (5)

Potency Measurements

ProteinTaxonomyMeasurementAverage (µ)Min (ref.)Avg (ref.)Max (ref.)Bioassay(s)
GLI family zinc finger 3Homo sapiens (human)Potency9.75760.000714.592883.7951AID1259369
retinoic acid nuclear receptor alpha variant 1Homo sapiens (human)Potency24.67250.003041.611522,387.1992AID1159552; AID1159555
pregnane X nuclear receptorHomo sapiens (human)Potency54.87070.005428.02631,258.9301AID1346982
vitamin D (1,25- dihydroxyvitamin D3) receptorHomo sapiens (human)Potency10.96350.023723.228263.5986AID743222
thyroid hormone receptor beta isoform 2Rattus norvegicus (Norway rat)Potency68.58960.000323.4451159.6830AID743066
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (65)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's15 (23.08)29.6817
2010's46 (70.77)24.3611
2020's4 (6.15)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 10.57

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index10.57 (24.57)
Research Supply Index4.20 (2.92)
Research Growth Index4.77 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (10.57)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other66 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]